Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Floris Vanommeslaeghe"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Prevention of clotting in hemodialysis (HD) is a concern, but tools to monitor anticoagulation strategies as well as data on bleeding and its impact on quality of life (QoL) are scant. In this prospective longitudinal observational study, bl
Externí odkaz:
https://doaj.org/article/cbc0139363a54c8d9c0a1dc33e6cd2e0
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Previous studies revealed the importance of biocompatibility, anticoagulation strategy, and dialysis mode and duration on fiber blocking at the end of a hemodialysis session. The present study was set up in ten hemodialysis patients to relat
Externí odkaz:
https://doaj.org/article/ec7a05ca67ee49a18659572933a52b7e
Autor:
Floris Vanommeslaeghe, Filip De Somer, Iván Josipovic, Matthieu Boone, Wim Van Biesen, Sunny Eloot
Publikováno v:
Kidney International Reports, Vol 4, Iss 11, Pp 1538-1545 (2019)
Introduction: Systemic anticoagulation is widely used in routine clinical hemodialysis, but can be contraindicated in specific settings. Anticoagulant-free treatment regimens are prone to failure even in chronic intermittent hemodialysis. We quantifi
Externí odkaz:
https://doaj.org/article/26209a1b470c4e18baf6b3f641ffd821
Autor:
Florence Bonkain, Jean-Claude Stolear, Concetta Catalano, Dominique Vandervelde, Serge Treille, Marie M Couttenye, Annemieke Dhondt, Mark Libertalis, Mandelina Allamani, Philippe Madhoun, Amaryllis H Van Craenenbroeck, Floris Vanommeslaeghe, Freya Van Hulle, Philippe Durieux, Ingrid Van Limberghen, Christian Tielemans, Karl Martin Wissing
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251793 (2021)
BackgroundThe efficacy and cost-effectiveness of prophylactic thrombolytic locks in hemodialysis patients at high-risk of thrombotic dialysis catheter dysfunction is uncertain. We investigated this question in a double-blinded randomized controlled s
Externí odkaz:
https://doaj.org/article/874c58bd249d4dae8b2a65bec877f305
Autor:
Raïsa Thielemans, Floris Vanommeslaeghe, Iván Josipovic, Filip De Somer, Katrien Devreese, Matthieu Boone, Wim Van Biesen, Sunny Eloot
Publikováno v:
Clinical Kidney Journal.
Background During extended (nocturnal) hemodialysis (ENHD), the dose of Low-Molecular-Weight Heparin (LMWH) can be administered as single injection or as divided dose over different time points. Our hypothesis was that a single injection might be suf
Autor:
Simon Malfait, W. Van Biesen, Y Vande Weygaerde, E Van Braeckel, Linos Vandekerckhove, F. Verbeke, Karim Vermaelen, Ruth Piers, Floris Vanommeslaeghe, N. Van Den Noortgate, J. De Clercq, Tania Desmet, Thomas J Malfait, Elizaveta Padalko, Fre Bauters, L Morbée, Dieter Stevens, Stien Vandendriessche, Frank Vermassen, Jerina Boelens, Liselotte Coorevits, Bruno Verhasselt, Katrien Hertegonne
Publikováno v:
Acta Clinica Belgica
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction: We present the results of the COVID-19 rule-out protocol at Ghent University Hospital, a step-wise testing approach which included repeat NFS SARS-CoV-2 rRT-PCR, respiratory multiplex RT-PCR, low-dose chest CT and bronchoscopy with BAL
Autor:
Wim Van Biesen, Iván Josipovic, Sunny Eloot, Floris Vanommeslaeghe, Matthieu Boone, Annemieke Dhondt, Arjan van der Tol
Publikováno v:
CLINICAL KIDNEY JOURNAL
Clinical Kidney Journal
Clinical Kidney Journal
Background While systemic anticoagulation is most widely used in haemodialysis (HD), contraindications to its use might occur in particular settings. The Solacea™ haemodialyser with an asymmetric triacetate membrane claims improved biocompatibility
Autor:
Michela Bozzetto, Sofia Poloni, Anna Caroli, Diego Curtò, Annick D’Haeninck, Floris Vanommeslaeghe, Nikola Gjorgjievski, Andrea Remuzzi
Background: The number of patients treated with hemodialysis (HD) in Europe is more than half a million and this number increases annually. The arteriovenous fistula (AVF) is the vascular access (VA) of first choice, but the clinical outcome is still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6f9f419afce93e29142aaa2ecc8b1d
http://hdl.handle.net/10446/203670
http://hdl.handle.net/10446/203670
Autor:
Iván Josipovic, Sunny Eloot, Wim Van Biesen, Annemieke Dhondt, Matthieu Boone, Floris Vanommeslaeghe
Publikováno v:
CLINICAL KIDNEY JOURNAL
Clinical Kidney Journal
Clinical Kidney Journal
Background Different strategies can be used to counteract coagulation of extracorporeal systems. Systemic anticoagulation is most widely used in routine clinical practice, but can be contraindicated in specific settings. The Solacea™ dialyser, cont
Autor:
Iván Josipovic, Sunny Eloot, Wim Van Biesen, Filip De Somer, Floris Vanommeslaeghe, Matthieu Boone
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 4, Iss 11, Pp 1538-1545 (2019)
Kidney International Reports, Vol 4, Iss 11, Pp 1538-1545 (2019)
Introduction Systemic anticoagulation is widely used in routine clinical hemodialysis, but can be contraindicated in specific settings. Anticoagulant-free treatment regimens are prone to failure even in chronic intermittent hemodialysis. We quantifie